
SAN DIEGO, CALIFORNIA / ACCESS Newswire / February 18, 2025 / Rancho BioSciences, the premier tech-enabled data science partner for biopharma, welcomes Bristol Myers Squibb (BMS) back for the 2nd phase of The Single-Cell Data Science Consortium. This continuing initiative aims to build on Phase 1's foundation, bringing together leading pharmaceutical companies with shared goals and needs in the realm of single-cell data.
The Single-Cell Data Science Consortium is a member-driven, pre-competitive collaboration to extract the value of single-cell data and establish a comprehensive data standard. This ambitious goal involves transforming vast amounts of public single-cell data into a unified standard that can significantly advance life sciences and drug discovery.
"BMS was one of the first members to join the consortium three years ago," said Julie Bryant, CEO of Rancho BioSciences. "Their continuing commitment is a testament to the quality and value this initiative is providing to its members."
Entering its fourth year, the consortium is on track to exceed the achievements of Phase 1. "Leveraging AI technologies and our team of PhD data science experts, we've delivered over 64 million professionally curated cells, nine atlases, as well as supporting data models and pipelines to date. This represents millions of dollars of value delivered to our members at a fraction of the cost and complication of attempting this alone. Phase 2 promises to deliver even more value to our members," added Bryant.
For more information about the Single-Cell Data Science Consortium and its initiatives, please visit Single-Cell Data Science - Data Science - Rancho BioSciences.
About Rancho BioSciences, LLC
Rancho BioSciences, LLC is a leading provider of tech enabled data science services, products and initiatives focused on life sciences. With a highly skilled team of PhD data scientists, curators, and bioinformaticians, Rancho BioSciences leverages data to accelerate medical research and enable new breakthroughs in treatment and care. Their mission, "Saving Lives Through Data," drives each project, helping clients harness the power of data to make life-saving discoveries. For more information about Rancho BioSciences, visit us at RanchoBioSciences.com or follow us on LinkedIn, YouTube and Facebook.
For media inquiries, please contact:
Julie Bryant
Phone: (760) 717-7881
Email: Julie.bryant@ranchobiosciences.com
Website: www.ranchobiosciences.com
SOURCE: Rancho BioSciences, LLC
View the original press release on ACCESS Newswire